Leukorrhea Panel Chlamydia Trachomatis, Neisseria Gonorrhoeae, Trichomonas Vaginalis

Total Page:16

File Type:pdf, Size:1020Kb

Leukorrhea Panel Chlamydia Trachomatis, Neisseria Gonorrhoeae, Trichomonas Vaginalis MEDICAL DIAGNOSTIC LABORATORIES, L.L.C. Leukorrhea Panel Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis The incubation period for C. trachomatis is 6-14 days. In Chlamydia trachomatis women, the primary site of infection is the cervix; specifically, EPIDEMIOLOGY columnar cells in the transitional zone and the endocervix. For this reason, it will not cause infections of the ectocervix Chlamydia is the most or vaginal walls. Cervical ectopy, or abnormal positioning common bacterial sexually of the cervix, can predispose one to chlamydial infection transmitted disease in the by exposing susceptible columnar epithelial cells. It is world with an estimated 90 estimated that 60% to 80% of sexually active adolescent million new cases annually females have cervical ectopy (1). This phenomenon may (1). It is the number one also account for the association between oral contraceptive reported disease in the use and chlamydia since women taking oral contraceptives United States (5). An estimated 3 million new cases occur are prone to cervical ectopy (1). each year in the U.S. alone (4). Rates of infection in the U.S. have steadily increased in the last 15 years. 1998- 2002 saw a higher incidence in the southern portion of the CLINICAL SIGNIFICANCE U.S. than in other regions (5). The highest incidence was in It is estimated that 80% of all infected individuals are adolescents and young adults, 15 to 24 years of age (4). In asymptomatic (3). Due to the lack of signs or symptoms 2004, a national study conducted from the University of North in some patients, it is believed that of all infected Carolina at Chapel Hill determined that 4.9% of young adults individuals, 25% of men and 40% of infected women in the U.S. were infected with chlamydia (15). Risk factors will go undiagnosed (6). Women who are symptomatic for infection include low socioeconomic status, young age, may experience abnormal vaginal discharge or a burning non-white race, unmarried, multiple sex partners, new sex sensation when urinating. If infection progresses into the partner, history of gonorrhea infection, and lack of barrier upper genital tract, they may experience lower abdominal contraceptive devices. pain, lower back pain, painful intercourse, nausea, fever, or bleeding between menstrual cycles. The appearance of PATHOGENESIS an infected cervix can vary greatly, from completely normal upon examination, to the presence of severe hypertrophic Chlamydia trachomatis, the cause of the sexually transmitted erosions and mucopurulent endocervical discharge. disease chlamydia, is an obligate intracellular parasite. This organism is unique, in that it is similar to both bacteria and In women, the most common manifestation of infection viruses. It is similar to bacteria because it contains RNA and is mucopurulent cervicitis. It is estimated that 20% of DNA and has a rigid cell wall. It is similar to viruses because women with mucopurulent cervicitis will harbor Chlamydia it is an obligate intracellular parasite that depends on the trachomatis (14). Lack of proper treatment of infection hosts cells for nutrients and energy. Much of the fibrosis and of the lower genital tract can progress to upper genital scarring associated with C. trachomatis infection is thought to tract infection and pelvic inflammatory disease (PID), be due, in large part, by a cell-mediated immune response. as well as other very serious complications, such as, Chlamydial heat-shock proteins (HSPS) share antigens with tubal factor infertility, ectopic pregnancy, chronic pelvic other bacterial and human HSPS. Therefore, the immune pain, lymphogranuloma venereum (LGV), endometritis, response cannot only target chlamydia, but host cells and salpingitis, and urethritis. Chlamydia infection can also tissues as well. The cytokine production associated with C. increase the risk for acquisition of HIV (2). trachomatis is one that is delayed and prolonged, as opposed to the quick short production associated with other pathogens. In pregnant women, chlamydia can have very serious Both of these characteristics, in combination with the often consequences including preterm delivery, low birth persistent infections of chlamydia, may account for many of weight, premature rupture of the membranes (PROM), the severe complications, including tubal factor infertility (1). and postpartum endometritis. There is a 60% to 70% risk of transmission of chlamydia to a neonate if it passes through the birth canal of an infected mother (1). It is antibody is used to stain the system for the evaluation estimated that 25% to 50% of exposed infants will develop of characteristic intracytoplasmic inclusions containing inclusion conjunctivitis within two weeks of birth and 10% to elementary and reticulate bodies of C. trachomatis. There 20% will develop pneumonia within 3 to 4 months of birth are certain disadvantages to this technique. Specimen (1). Chlamydia trachomatis is implicated in 20% to 60% viability is greatly affected by collection techniques and of all pneumonias during the first six months of life (14). transport conditions. Results may take anywhere from 3 to Transmission is not known to occur in-utero. Therefore, 7 days depending on growth. Although specificity is nearly neonates delivered by C-section are not at risk unless there 100%, reported sensitivity is as low as 70% to 85% (3). is premature rupture of the membranes. Therefore, culture is not a good screening test. In men, symptoms include difficulty urinating, pain or burning Point-of-care tests have recently been introduced. They can upon urination, penile discharge, testicular tenderness, and typically be performed within 30 minutes in the physician’s redness or swelling of the urethral opening at the tip of office. In some settings, such as in clinics, it may be useful the penis. Complications can include prostatitis, proctitis, to have an immediate answer if it is anticipated that the epididymitis, sterility, or narrowing (stricture) of the urethra patient may not return. These tests use antibodies that that may require surgery to correct. target lipopolysaccharides (LPS) that are found in all chlamydia species as well as other microorganisms that Some complications can occur in both men and women. could produce false-positive results (4). Point-of-care Lymphogranuloma venereum is a manifestation of tests have the lowest reported sensitivity and specificity Chlamydia trachomatis that primarily infects the lymph of any test available, 52% to 85% and 95% respectively system. Although cases do occur sporadically in the (3). These tests are generally not recommended due to U.S., it is usually associated with recent travel to endemic the lack of quality control as well as poor performance countries. Reiter’s syndrome consists of a classic triad of characteristics. urethritis, conjunctivitis, and reactive arthritis. Patients may also exhibit characteristic mucocutaneous lesions. Other Table 1. Sensitivities of Chlamydia trachomatis detection tests. sites of infection can include the throat (pharyngitis), rectum Method Sensitivity (proctatitis), and eye (conjunctivitis). Gram Stain 20% DIAGNOSIS Cell Culture 70% - 85% Laboratory diagnosis of chlamydia is crucial for definitive Point-of-Care Testing 52% - 85% diagnosis. Gram stain is not possible due to the lack of Enzyme immunoassay (EIA) 60% - 80% peptidoglycan in the cell wall. Cytological techniques consist Direct Fluorescent assay (DFA) 60% - 80% of Giemsa-stained cell scrapings that are visually inspected Pace-2 GenProbe 75% for cells with inclusion bodies. This technique is only useful in diagnosing inclusion conjunctivitis in newborns. Studies Hybrid Capture-II (HCII) Digene 75% Transcription Mediated Amplification show that only 20% of cervical infections are detected in this 89% manner (1). (TMA) GenProbe APTIMA 2 Strand Displacement Technology (SDA) 84% Serological methods have a very limited value when Becton Dickinson BDProbeTec investigating uncomplicated genital tract infection (4). Ligase Chain Reaction (LCR) 86% They are often inconclusive due to the long-lasting Abbott LCx immune response that may be present from a previous Real-Time PCR Technology 99% infection and the cross-reactivity with other bacteria including other chlamydia species. Therefore, serological Enzyme immunoassays (EIA) use immunohistochemical assays, such as the complement fixation test and the reactions to detect chlamydial antigens. However, microimmunofluorescence test are not appropriate specimen viability can be affected by collection techniques screening methods. and transport conditions. The reported sensitivity of this assay is approximately 60% to 80% (10, 11). Many of these Due to the fact that Chlamydia trachomatis is an obligate assays also target lipopolysaccharides (LPS) that are found intracellular parasite, it cannot be cultured on artificial in all chlamydia species as well as other microorganisms media. Cell culture techniques are commonly utilized. that could produce false-positive results (4). Therefore The specimen is introduced into a susceptible cell line in a specificity is low as well. They require either blocking tissue culture system. A fluorescein-conjugated monoclonal assays or confirmatory assays for all positive specimens. Direct fluorescent antibody (DFA) techniques use with chemiluminescent DNA probes are used to visualize the fluoroscein-labeled specific antibodies to detect chlamydial rRNA amplification products spectrophotometrically. Due antigens. The specimen is applied
Recommended publications
  • Genetic Diversity of Bartonella Species in Small Mammals in the Qaidam
    www.nature.com/scientificreports OPEN Genetic diversity of Bartonella species in small mammals in the Qaidam Basin, western China Huaxiang Rao1, Shoujiang Li3, Liang Lu4, Rong Wang3, Xiuping Song4, Kai Sun5, Yan Shi3, Dongmei Li4* & Juan Yu2* Investigation of the prevalence and diversity of Bartonella infections in small mammals in the Qaidam Basin, western China, could provide a scientifc basis for the control and prevention of Bartonella infections in humans. Accordingly, in this study, small mammals were captured using snap traps in Wulan County and Ge’ermu City, Qaidam Basin, China. Spleen and brain tissues were collected and cultured to isolate Bartonella strains. The suspected positive colonies were detected with polymerase chain reaction amplifcation and sequencing of gltA, ftsZ, RNA polymerase beta subunit (rpoB) and ribC genes. Among 101 small mammals, 39 were positive for Bartonella, with the infection rate of 38.61%. The infection rate in diferent tissues (spleens and brains) (χ2 = 0.112, P = 0.738) and gender (χ2 = 1.927, P = 0.165) of small mammals did not have statistical diference, but that in diferent habitats had statistical diference (χ2 = 10.361, P = 0.016). Through genetic evolution analysis, 40 Bartonella strains were identifed (two diferent Bartonella species were detected in one small mammal), including B. grahamii (30), B. jaculi (3), B. krasnovii (3) and Candidatus B. gerbillinarum (4), which showed rodent-specifc characteristics. B. grahamii was the dominant epidemic strain (accounted for 75.0%). Furthermore, phylogenetic analysis showed that B. grahamii in the Qaidam Basin, might be close to the strains isolated from Japan and China.
    [Show full text]
  • Symptomatology of Endometriosis : with a Survey of 788 Cases Compiled from the Literature
    University of Nebraska Medical Center DigitalCommons@UNMC MD Theses Special Collections 5-1-1938 Symptomatology of endometriosis : with a survey of 788 cases compiled from the literature Paul Milton Pedersen University of Nebraska Medical Center This manuscript is historical in nature and may not reflect current medical research and practice. Search PubMed for current research. Follow this and additional works at: https://digitalcommons.unmc.edu/mdtheses Part of the Medical Education Commons Recommended Citation Pedersen, Paul Milton, "Symptomatology of endometriosis : with a survey of 788 cases compiled from the literature" (1938). MD Theses. 688. https://digitalcommons.unmc.edu/mdtheses/688 This Thesis is brought to you for free and open access by the Special Collections at DigitalCommons@UNMC. It has been accepted for inclusion in MD Theses by an authorized administrator of DigitalCommons@UNMC. For more information, please contact [email protected]. THE SYMPTOMATOLOGY OF ENDOMETRIOSIS WITH A SURVEY OF 788 CASES COMPILED FROM LITERATURE SENIOR THESIS PAUL MILTON PEDERSEN *** j I !,' i PRESENTED TO THE THE UNIVERSITY OF NEBRASKA OJIAHA., 1938 .. 480965 THE SYMPTOMATOLOGY OF ENDOMETRIOSIS WITH A SURVEY OF 788 CASES COMPILED FROM LITERATURE Introduction. The history of this disease is very similar to that of many others in that it has been developed as a clinical entity within the past twenty years. The present day knowledge of the subject is not as general as it might· be considering the relatively numerous articles which have appeared upon this subject within the past five years. Endometriosis is a very intriguing subject; the unique features in the symptoms that it provokes are indeed class­ ical, and the interest with which this is regarded has caused us to consider that phase in detail.
    [Show full text]
  • Amenorrhea in Teenagers in Concepts of Homoeopathy
    Amenorrhea in Teenagers in concepts of Homoeopathy © Dr. Rajneesh Kumar Sharma MD (Homoeopathy) Homoeo Cure Research Institute NH 74- Moradabad Road Kashipur (UTTARANCHAL) - INDIA Ph- 09897618594 E. mail- [email protected] www.homeopathictreatment.org.in www.treatmenthomeopathy.com www.homeopathyworldcommunity.com Introduction Menstrual irregularities are common within first 2–3 years after menarche. If amenorrhea is prolonged, it is abnormal and can be associated with some major disease, depending on the adolescent whether she is oestrogen-deficient or oestrogen-replete. Oestrogen-deficient amenorrhea (Psora) is concomitant with reduced bone mineral density (Syphilis) and increased fracture risk, while oestrogen-replete amenorrhea (Syphilis) can lead to dysfunctional uterine bleeding in the short term (Pseudopsora/ Sycosis) and predispose to endometrial carcinoma (Cancerous) in the long term. Hypothalamic amenorrhea (Psora) is predominant cause of amenorrhea in the adolescents and often leads to polycystic ovary syndrome (Pseudopsora/ Sycosis). In anorexia nervosa (Psora), exercise- induced amenorrhea (Causa occasionalis) and chronic illness amenorrhea, energy shortage results in suppression of GnRH secretion (Psora) by hypothalamus. Normal Menstrual Cycle Menarche Menarche is the time when a girl has her first menstrual period. It usually occurs between the ages of 10 and 14 years. Physiology Stimulation of Pituitary Neurosecretory neurons of the preoptic area of the hypothalamus secrete a decapeptide, called Gonadotropin-releasing hormone (GnRH). This hormone is poured into the capillaries of the hypophysial portal system which transport it to the anterior pituitary, where it stimulates (Psora) the synthesis and secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Control of GnRH The GnRH is released in rhythms in response to serum levels of gonadal steroids.
    [Show full text]
  • The Differential Diagnosis of Acute Pelvic Pain in Various Stages of The
    Osteopathic Family Physician (2011) 3, 112-119 The differential diagnosis of acute pelvic pain in various stages of the life cycle of women and adolescents: gynecological challenges for the family physician in an outpatient setting Maria F. Daly, DO, FACOFP From Jackson Memorial Hospital, Miami, FL. KEYWORDS: Acute pain is of sudden onset, intense, sharp or severe cramping. It may be described as local or diffuse, Acute pain; and if corrected takes a short course. It is often associated with nausea, emesis, diaphoresis, and anxiety. Acute pelvic pain; It may vary in intensity of expression by a woman’s cultural worldview of communicating as well as Nonpelvic pain; her history of physical, mental, and psychosocial painful experiences. The primary care physician must Differential diagnosis dissect in an orderly, precise, and rapid manner the true history from the patient experiencing pain, and proceed to diagnose and treat the acute symptoms of a possible life-threatening problem. © 2011 Elsevier Inc. All rights reserved. Introduction female’s presentation of acute pelvic pain with an enlarged bulky uterus may often be diagnosed as a leiomyoma in- Women at various ages and stages of their life cycle may stead of a neoplastic mass. A pregnant female, whose preg- present with different causes of acute pelvic pain. Estab- nancy is either known to her or unknown, presenting with lishing an accurate diagnosis from the multiple pathologies acute pelvic pain must be rapidly evaluated and treated to in the differential diagnosis of their specific pelvic pain may prevent a rapid downward cascading progression to mater- well be a challenge for the primary care physician.
    [Show full text]
  • Endocarditis Due to Bartonella Quintana, the Etiological Agent of Trench Fever
    PRACTICE | CASES CPD VULNERABLE POPULATIONS Endocarditis due to Bartonella quintana, the etiological agent of trench fever Carl Boodman MD, Terence Wuerz MD MSc (Epi), Philippe Lagacé-Wiens MD n Cite as: CMAJ 2020 December 7;192:E1723-6. doi: 10.1503/cmaj.201170 CMAJ Podcasts: author interview at www.cmaj.ca/lookup/doi/10.1503/cmaj.201170/tab-related-content 48-year-old man presented to the emergency depart- ment with a 2-day history of pleuritic chest pain and KEY POINTS shortness of breath. His medical history included HIV • Bartonella quintana, the causal agent of trench fever, is infection,A diagnosed 14 years earlier in the context of intraven- transmitted by body lice (Pediculus humanus var. corporis). ous drug use. Three months previously, he had an undetectable • Although B. quintana is notorious for causing disease in the First viral load and a CD4 count of 94 cells/mm3 (normal range: 500– World War, outbreaks of trench fever have recently occurred in 1400 cells/mm3) or 0.09 (normal range 0.50–1.40) × 109/L. The urban populations experiencing homelessness. patient adhered to his prescribed antiretroviral regimen (darunavir, • B. quintana causes culture-negative endocarditis and may be ritonavir and abacavir-lamivudine) and prophylaxis against oppor- fatal without antimicrobial and surgical treatment, despite mild tunistic infections (valacyclovir, trimethoprim-sulfamethoxazole symptomatology during chronic bacteremia. Consultation with infectious disease specialists is encouraged. and fluconazole). In addition, the patient had a congenital soli- Because B. quintana evades identification in routine blood tary kidney with normal baseline renal function, alcohol expos- • cultures, diagnosis of B.
    [Show full text]
  • The Approved List of Biological Agents Advisory Committee on Dangerous Pathogens Health and Safety Executive
    The Approved List of biological agents Advisory Committee on Dangerous Pathogens Health and Safety Executive © Crown copyright 2021 First published 2000 Second edition 2004 Third edition 2013 Fourth edition 2021 You may reuse this information (excluding logos) free of charge in any format or medium, under the terms of the Open Government Licence. To view the licence visit www.nationalarchives.gov.uk/doc/ open-government-licence/, write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email [email protected]. Some images and illustrations may not be owned by the Crown so cannot be reproduced without permission of the copyright owner. Enquiries should be sent to [email protected]. The Control of Substances Hazardous to Health Regulations 2002 refer to an ‘approved classification of a biological agent’, which means the classification of that agent approved by the Health and Safety Executive (HSE). This list is approved by HSE for that purpose. This edition of the Approved List has effect from 12 July 2021. On that date the previous edition of the list approved by the Health and Safety Executive on the 1 July 2013 will cease to have effect. This list will be reviewed periodically, the next review is due in February 2022. The Advisory Committee on Dangerous Pathogens (ACDP) prepares the Approved List included in this publication. ACDP advises HSE, and Ministers for the Department of Health and Social Care and the Department for the Environment, Food & Rural Affairs and their counterparts under devolution in Scotland, Wales & Northern Ireland, as required, on all aspects of hazards and risks to workers and others from exposure to pathogens.
    [Show full text]
  • Bartonella: Feline Diseases and Emerging Zoonosis
    BARTONELLA: FELINE DISEASES AND EMERGING ZOONOSIS WILLIAM D. HARDY, JR., V.M.D. Director National Veterinary Laboratory, Inc. P.O Box 239 Franklin Lakes, New Jersey 07417 201-891-2992 www.natvetlab.com or .net Gingivitis Proliferative Gingivitis Conjunctivitis/Blepharitis Uveitis & Conjunctivitis URI Oral Ulcers Stomatitis Lymphadenopathy TABLE OF CONTENTS Page SUMMARY……………………………………………………………………………………... i INTRODUCTION……………………………………………………………………………… 1 MICROBIOLOGY……………………………………………………………………………... 1 METHODS OF DETECTION OF BARTONELLA INFECTION.………………………….. 1 Isolation from Blood…………………………………………………………………….. 2 Serologic Tests…………………………………………………………………………… 2 SEROLOGY……………………………………………………………………………………… 3 CATS: PREVALENCE OF BARTONELLA INFECTIONS…………………………………… 4 Geographic Risk factors for Infection……………………………………………………. 5 Risk Factors for Infection………………………………………………………………… 5 FELINE BARTONELLA DISEASES………………………………………………………….… 6 Bartonella Pathogenesis………………………………………………………………… 7 Therapy of Feline Bartonella Diseases…………………………………………………… 14 Clinical Therapy Results…………………………………………………………………. 15 DOGS: PREVALENCE OF BARTONELLA INFECTIONS…………………………………. 17 CANINE BARTONELLA DISEASES…………………………………………………………... 17 HUMAN BARTONELLA DISEASES…………………………………………………………… 18 Zoonotic Case Study……………………………………………………………………... 21 FELINE BLOOD DONORS……………………………………………………………………. 21 REFERENCES………………………………………………………………………………….. 22 This work was initiated while Dr. Hardy was: Professor of Medicine, Albert Einstein College of Medicine of Yeshiva University, Bronx, New York and Director,
    [Show full text]
  • Bartonella Species Isolated from Rodents, Greece
    LETTERS Bartonella Species Germany). Polymerase chain reaction (AY435104–AY435113, isolated from (PCR) was performed by using two A. flavicollis) and representing four Isolated from oligonucleotides specific for the cit- novel genotypes, was 98% similar to Rodents, Greece rate synthase (gltA) gene of B. hense- B. taylorii (AF191502, isolated from lae Houston 1, primers BhCS 781.p A. sylvaticus) gltA gene. The second To the Editor: Domestic cats and and BhCS 1137.n. Negative and posi- group, consisting of seven isolates that human body lice have been identified tive controls (double-distilled H2O shared the same genotype (AY435114- as the vectors of Bartonella henselae and DNA from cultures of B. hense- AY435120 isolated from A. flavicol- and B. quintana, respectively, the pri- lae) were used in each PCR run. lis), was 99% similar to B. birtlesii mary sources of Bartonella-associat- Products of the correct size were puri- (AF204272 isolated from Apodemus ed human diseases (1). Bartonella fied (QIAquick PCR Purification kit, spp.). The third group consisted of two species are zoonotic agents that have Qiagen GmbH) and sequenced with isolates that shared the same genotype been isolated from a wide range of the same primers, BhCS 781.p and (AY435121 isolated from D. nitedula, mammals in the United States (2) and BhCS1137.n., in both directions, with and AY435122 isolated from A. flavi- Europe (3) and have been associated the Cy5/Cy5.5 Dye Primer Cycle collis); this group was 97% similar to with human diseases (4–5). Sequencing kit on a Long-Read B. grahamii strain V2 (Z70016 isolat- This study investigated the poten- Tower sequencer (Visible Genetics ed from Neomys fodiens).
    [Show full text]
  • Bacterial Vaginosis – More Questions Than Answers
    THEME SEXUAL HEALTH Marie Pirotta Kath A Fethers Catriona S Bradshaw MBBS, FRACGP, DipRANZOCG, MMed (WomHlth), MBBS, MM, FAChSHM, is MBBS(Hons), FAChSHM, PhD, is a sexual PhD, is a general practitioner and Senior Research a sexual health physician, health physician and NHMRC Research Fellow, Fellow, Primary Care Research Unit, Department Melbourne Sexual Health Department of Epidemiology and Preventive of General Practice, University of Melbourne, Centre, Victoria. Medicine, Monash University and Melbourne Victoria. [email protected] Sexual Health Centre, The Alfred Hospital, Victoria. Bacterial vaginosis More questions than answers Bacterial vaginosis (BV) is one of the commonest genital Background conditions ocurring in women of reproductive age. In public Bacterial vaginosis is the commonest cause of abnormal vaginal health terms, it plays a significant role as a risk factor for a discharge in women of reproductive age and is associated with wide range of health problems, including preterm birth, serious pregnancy related sequelae and increased transmission of sexually transmissible infections, including HIV. The aetiology, spontaneous abortion, and enhanced transmission of sexually pathology, microbiology and transmission of bacterial vaginosis transmissible infections (STIs), including human remain poorly understood. immunodeficiency virus (HIV). Objective Previous names for BV include: ‘leukorrhea’, ‘nonspecific vaginitis’, This article discusses the prevalence, clinical features and ‘haemophilus vaginalis vaginitis’, ‘gardnerella’ and ‘anaerobic possible complications of bacterial vaginosis. It summarises what is known about the aetiology, pathophysiology and vaginitis’. Its changing name belies the interesting fact that, despite treatment of the condition and highlights directions for further an increased understanding of its physiology and sequelae, the research. precise pathogenesis of BV remains controversial and it's aetiology, pathology, microbiology and transmission is still poorly understood.
    [Show full text]
  • Pelvic Inflammatory Disease in the Postmenopausal Woman
    Infectious Diseases in Obstetrics and Gynecology 7:248-252 (1999) (C) 1999 Wiley-Liss, Inc. Pelvic Inflammatory Disease in the Postmenopausal Woman S.L. Jackson* and D.E. Soper Department of Obstetrics and Gynecology, Medical University of South Carolina, Charleston, SC ABSTRACT Objective: Review available literature on pelvic inflammatory disease in postmenopausal women. Design: MEDLINE literature review from 1966 to 1999. Results: Pelvic inflammatory disease is uncommon in postmenopausal women. It is polymicro- bial, often is concurrent with tuboovarian abscess formation, and is often associated with other diagnoses. Conclusion: Postmenopausal women with pelvic inflammatory disease are best treated with in- patient parenteral antimicrobials and appropriate imaging studies. Failure to respond to antibiotics should yield a low threshold for surgery, and consideration of alternative diagnoses should be entertained. Infect. Dis. Obstet. Gynecol. 7:248-252, 1999. (C) 1999Wiley-Liss, Inc. KEY WORDS menopause; tuboovarian abscess; diverticulitis elvic inflammatory disease (PID) is a common stance abuse, lack of barrier contraception, use of and serious complication of sexually transmit- an intrauterine device (IUD), and vaginal douch- ted diseases in young women but is rarely diag- ing. z The pathophysiology involves the ascending nosed in the postmenopausal woman. The epide- spread of pathogens initially found within the en- miology of PlD,.as well as the changes that occur in docervix, with the most common etiologic agents the genital tract of postmenopausal women, ex- being the sexually transmitted microorganisms plain this discrepancy. The exact incidence of PID Neisseria gonorrhoeae and Chlamydia trachomatis. in postmenopausal women is unknown; however, These bacteria are identified in 60-75% of pre- in one series, fewer than 2% of women with tubo- menopausal women with PID.
    [Show full text]
  • INFECTIOUS DISEASES of HAITI Free
    INFECTIOUS DISEASES OF HAITI Free. Promotional use only - not for resale. Infectious Diseases of Haiti - 2010 edition Infectious Diseases of Haiti - 2010 edition Copyright © 2010 by GIDEON Informatics, Inc. All rights reserved. Published by GIDEON Informatics, Inc, Los Angeles, California, USA. www.gideononline.com Cover design by GIDEON Informatics, Inc No part of this book may be reproduced or transmitted in any form or by any means without written permission from the publisher. Contact GIDEON Informatics at [email protected]. ISBN-13: 978-1-61755-090-4 ISBN-10: 1-61755-090-6 Visit http://www.gideononline.com/ebooks/ for the up to date list of GIDEON ebooks. DISCLAIMER: Publisher assumes no liability to patients with respect to the actions of physicians, health care facilities and other users, and is not responsible for any injury, death or damage resulting from the use, misuse or interpretation of information obtained through this book. Therapeutic options listed are limited to published studies and reviews. Therapy should not be undertaken without a thorough assessment of the indications, contraindications and side effects of any prospective drug or intervention. Furthermore, the data for the book are largely derived from incidence and prevalence statistics whose accuracy will vary widely for individual diseases and countries. Changes in endemicity, incidence, and drugs of choice may occur. The list of drugs, infectious diseases and even country names will vary with time. © 2010 GIDEON Informatics, Inc. www.gideononline.com All Rights Reserved. Page 2 of 314 Free. Promotional use only - not for resale. Infectious Diseases of Haiti - 2010 edition Introduction: The GIDEON e-book series Infectious Diseases of Haiti is one in a series of GIDEON ebooks which summarize the status of individual infectious diseases, in every country of the world.
    [Show full text]
  • 555 BCBSA Reference Number: 2.04.10 NCD/LCD: N/A
    Medical Policy Identification of Microorganisms Using Nucleic Acid Probes Table of Contents • Policy: Commercial • Coding Information • Information Pertaining to All Policies • Policy: Medicare • Description • References • Authorization Information • Policy History • Endnotes Policy Number: 555 BCBSA Reference Number: 2.04.10 NCD/LCD: N/A Related Policies • Intravenous Antibiotic Therapy and Associated Diagnostic Testing for Lyme Disease, #171 • Multitarget Polymerase Chain Reaction Testing for Diagnosis of Bacterial Vaginosis, #711 Policy Commercial Members: Managed Care (HMO and POS), PPO, and Indemnity Medicare HMO BlueSM and Medicare PPO BlueSM Members The use of nucleic acid testing using a direct or amplified probe technique (without quantification of viral load) may be considered MEDICALLY NECESSARY for the following microorganisms: • Bartonella henselae or quintana • Bordetella pertussis • Candida species • Chlamydia pneumoniae • Chlamydiatrachomatis • Clostridium difficile • Enterococcus, vancomycin-resistant (eg, enterococcus vanA, vanB) • Enterovirus • Herpes simplex virus • Human papillomavirus • Influenza virus • Legionella pneumophila • Mumps • Mycobacterium species • Mycobacterium tuberculosis • Mycobacterium avium intracellulare • Mycoplasma pneumoniae • Neisseria gonorrhoeae 1 • Rubeola (measles) • Staphylococcus aureus • Staphylococcus aureus, methicillin resistant • Streptococcus, group A • Streptococcus, group B • Trichomonas vaginalis • Zika virus. The use of molecular diagnostics for the diagnosis and management
    [Show full text]